On June 28th, ASBM Chairman Harry L. Gewanter, MD presented to an audience of 150 at the 8th Latin American Biosimilars Forum in Brasilia, Brazil.
In his presentation, entitled “Increasing Physician Confidence in Biosimilars”, Dr. Gewanter discussed barriers to widespread acceptance of biosimilars among physicians.
Dr. Gewanter cited the example of Australia, where biosimilar uptake remains low due to a lack of clinical and post-market data that would build physician confidence and increase biosimilar usage. He went on to urge regulators to adopt other policies which build physician confidence, such as embracing the WHO’s distinct naming proposal and requiring informative and transparent labeling of biosimilars.
View Dr. Gewanter’s presentation here.